Method and Apparatus for Cancer Screening
A method and apparatus for detection of pteridine levels in a biological sample using CE-LIF which is useful for early cancer screening involving fully oxidizing pteridine compounds in a sample such as a urine sample, subjecting to CE-LIF to assess compound concentration, and compare to expected levels in for healthy or cancer-bearing patients.
Patents:US 20,110,147,217
Inventor(s):
MA YINFA [US]; GIBBONS STEPHEN [US]
Type of Offer:
Licensing
« More Biomedical Patents